Daniel Zips Selected Research

fluoromisonidazole

1/2022	Dose escalation to hypoxic subvolumes in head and neck cancer: A randomized phase II study using dynamic [18F]FMISO PET/CT.
1/2021	Generation of biological hypotheses by functional imaging links tumor hypoxia to radiation induced tissue inflammation/glucose uptake in head and neck cancer.
7/2020	Comparison of patient stratification by computed tomography radiomics and hypoxia positron emission tomography in head-and-neck cancer radiotherapy.
1/2020	Individual patient data meta-analysis of FMISO and FAZA hypoxia PET scans from head and neck cancer patients undergoing definitive radio-chemotherapy.
12/2019	Prospective Evaluation of a Tumor Control Probability Model Based on Dynamic 18F-FMISO PET for Head and Neck Cancer Radiotherapy.
2/2019	Correlation between FMISO-PET based hypoxia in the primary tumour and in lymph node metastases in locally advanced HNSCC patients.
1/2019	Repeat FMISO-PET imaging weakly correlates with hypoxia-associated gene expressions for locally advanced HNSCC treated by primary radiochemotherapy.
1/2019	FMISO-PET-based lymph node hypoxia adds to the prognostic value of tumor only hypoxia in HNSCC patients.
11/2017	Overlap of highly FDG-avid and FMISO hypoxic tumor subvolumes in patients with head and neck cancer.
11/2017	Geometric analysis of loco-regional recurrences in relation to pre-treatment hypoxia in patients with head and neck cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Zips Research Topics

Disease

73	Neoplasms (Cancer) 02/2022 - 01/2002
37	Squamous Cell Carcinoma of Head and Neck 06/2022 - 01/2010
35	Hypoxia (Hypoxemia) 01/2022 - 06/2004
27	Prostatic Neoplasms (Prostate Cancer) 04/2022 - 12/2007
21	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022 - 10/2012
20	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 02/2002
11	Rectal Neoplasms (Rectal Cancer) 04/2022 - 01/2016
11	Neoplasm Metastasis (Metastasis) 04/2022 - 10/2014
9	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2005
9	Hyperthermia 03/2021 - 07/2015
5	Sarcoma (Soft Tissue Sarcoma) 11/2021 - 01/2018
5	Carcinoma (Carcinomatosis) 04/2021 - 12/2014
4	Lymphatic Metastasis 02/2019 - 05/2011
4	Body Weight (Weight, Body) 12/2014 - 03/2005
3	Brain Neoplasms (Brain Tumor) 01/2022 - 03/2016
3	Breast Neoplasms (Breast Cancer) 09/2021 - 01/2021
3	Meningioma (Meningiomas) 06/2021 - 12/2019
3	Melanoma (Melanoma, Malignant) 01/2019 - 10/2014
3	Lung Neoplasms (Lung Cancer) 02/2018 - 08/2004
2	Infections 02/2022 - 12/2018
2	Disease Progression 01/2022 - 03/2021
2	Fatigue 09/2021 - 04/2021
2	Inflammation (Inflammations) 01/2021 - 12/2018
2	Glioma (Gliomas) 01/2020 - 09/2015
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 03/2019 - 10/2013
2	Deglutition Disorders (Dysphagia) 10/2018 - 01/2015
2	Necrosis 01/2017 - 06/2005
2	Rhabdomyosarcoma 01/2017 - 11/2016
1	Alcoholism (Alcohol Abuse) 10/2021
1	Chronic Disease (Chronic Diseases) 09/2021
1	Triple Negative Breast Neoplasms 09/2020
1	Gynecomastia 07/2020

Drug/Important Bio-Agent (IBA)

20	fluoromisonidazoleIBA 01/2022 - 10/2012
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2006
12	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2014
10	pimonidazoleIBA 11/2012 - 08/2005
7	Proteins (Proteins, Gene)FDA Link 02/2022 - 01/2016
6	Messenger RNA (mRNA)IBA 01/2022 - 09/2015
6	Cisplatin (Platino)FDA LinkGeneric 04/2021 - 12/2014
6	Biological ProductsIBA 01/2021 - 12/2007
5	Pharmaceutical PreparationsIBA 10/2021 - 03/2005
4	AndrogensIBA 01/2022 - 01/2018
4	Oxygen (Dioxygen)IBA 10/2021 - 10/2013
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2006
4	Phosphotransferases (Kinase)IBA 08/2017 - 03/2005
4	Lactic Acid (Lactate)FDA LinkGeneric 07/2010 - 11/2006
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 11/2006
3	Fura-2 (Fura 2)IBA 01/2020 - 03/2016
3	CytokinesIBA 04/2018 - 01/2017
3	bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA 11/2012 - 09/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2012 - 03/2005
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2005 - 09/2003
3	vatalanib (PTK787)IBA 06/2005 - 09/2003
2	Prostate-Specific Antigen (Semenogelase)IBA 04/2022 - 12/2020
2	Hormones (Hormone)IBA 01/2022 - 01/2021
2	AntigensIBA 01/2022 - 11/2012
2	Fluorouracil (Carac)FDA LinkGeneric 11/2021 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2017
2	Complement System Proteins (Complement)IBA 09/2019 - 12/2018
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	Radiation-Sensitizing AgentsIBA 09/2015 - 05/2007
2	Protons (Proton)IBA 01/2015 - 11/2006
2	NitroimidazolesIBA 01/2015 - 06/2004
2	AfatinibIBA 12/2014 - 05/2007
2	Cetuximab (Erbitux)FDA Link 02/2014 - 01/2013
2	Plasminogen Activator Inhibitor 1IBA 11/2012 - 03/2008
2	Pyruvic Acid (Pyruvate)IBA 01/2010 - 11/2006
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2007 - 06/2005
2	Tyrosine Kinase InhibitorsIBA 05/2007 - 03/2005
2	Tyrosine (L-Tyrosine)FDA Link 06/2005 - 03/2005
1	HMGB1 Protein (HMG1)IBA 02/2022
1	NestinIBA 01/2022
1	Gallium-68IBA 01/2022
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 11/2021
1	Aldehyde DehydrogenaseIBA 10/2021
1	Disulfiram (Antabuse)FDA Link 10/2021
1	IonsIBA 10/2021
1	Oncogene Proteins (Oncogene Protein)IBA 10/2021
1	Somatostatin Receptors (Somatostatin Receptor)IBA 06/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	Serine (L-Serine)FDA Link 09/2020

Therapy/Procedure

75	Radiotherapy 06/2022 - 06/2004
44	Chemoradiotherapy 02/2022 - 10/2012
33	Therapeutics 02/2022 - 07/2010
14	Drug Therapy (Chemotherapy) 06/2022 - 07/2010
6	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 06/2021 - 01/2013
6	Immunotherapy 01/2019 - 01/2017
4	Image-Guided Radiotherapy 04/2022 - 07/2015
3	Particle Accelerators 09/2021 - 01/2021
3	Neoadjuvant Therapy 03/2021 - 05/2011
2	Castration 04/2022 - 01/2022
2	Prostatectomy (Retropubic Prostatectomy) 03/2021 - 01/2018
2	Gastrostomy 12/2018 - 10/2018
2	Radioimmunotherapy 04/2018 - 02/2014
2	Brachytherapy 11/2016 - 12/2007
2	Proton Therapy 08/2015 - 01/2015
1	Lymph Node Excision (Lymph Node Dissection) 01/2022
1	Fitness Trackers 09/2021
1	Aftercare (After-Treatment) 09/2021
1	Off-Label Use 07/2020